Your session is about to expire
← Back to Search
Chemotherapy Toxicity Risk Tool for Cancer
N/A
Waitlist Available
Research Sponsored by Masonic Cancer Center, University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3 and 6 months of the index visit with the oncologist
Awards & highlights
Study Summary
This trial will test a tool to help doctors assess risk of chemo side effects for cancer patients.
Who is the study for?
This trial is for people over 65 who have just been diagnosed with cancer and are seeing an oncologist for the first time, without any previous chemotherapy. It's not for those lacking electronic health records after their first visit or who don't consent to research.Check my eligibility
What is being tested?
The study is testing a new tool in electronic medical records that helps cancer doctors predict how likely patients are to experience side effects from chemotherapy during their initial consultation.See study design
What are the potential side effects?
While this trial focuses on a risk calculator tool rather than direct medication, potential side effects would relate to the standard risks associated with chemotherapy which can include nausea, fatigue, hair loss, and increased infection risk.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 3 and 6 months of the index visit with the oncologist
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3 and 6 months of the index visit with the oncologist
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Unplanned hospitalization rate
Secondary outcome measures
Chemotherapy modification rate
Chemotherapy toxicity tool use rate
Chemotherapy use rate
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Chemotherapy Toxicity ToolExperimental Treatment2 Interventions
Group II: Usual CarePlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Masonic Cancer Center, University of MinnesotaLead Sponsor
271 Previous Clinical Trials
14,591 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a new patient to an oncologist for cancer treatment, having not previously received chemotherapy.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Chemotherapy Toxicity Tool
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for new participants in this research?
"The clinical trial's information hosted on clinicaltrials.gov confirms that no more participants are being sought for this study, which first launched January 9th 2023 and was most recently updated March 30th 2023. Although this medical experiment has closed registration, there exists a plethora of other trials currently open to applicants at the moment numbering 2504 in total."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger